TECHNOLOGY

HIGH-SPECIFICITY CANCER TARGETING

Using its proprietary platform technology, EM Imaging is developing a pipeline of highly novel in vivo c-Met targeting theragnostic and optical imaging agents that will alter the landscape of precision medicine.

Find out about our Technology


PIPELINE

Edinburgh Molecular Imaging has a portfolio of agents addressing a number of unmet medical needs.

Find out about our Pipeline


ONGOING CLINICAL STUDIES

Find out more here


LATEST NEWS

adminHome 2